Awc. Kung et al., Epitope mapping of TSH receptor-blocking antibodies in Graves' disease that appear during pregnancy, J CLIN END, 86(8), 2001, pp. 3647-3653
Spontaneous remission of Graves' disease during pregnancy is thought to be
due to a reduction of thyroid-stimulating antibody activity. We suspected,
however, that a broader change in TSH receptor antibody characteristics mig
ht play an important role in modulating disease activity during pregnancy.
We measured TSH binding inhibitory Ig, thyroid-stimulating antibody, and th
yroid stimulating-blocking antibody activities in 13 pregnant Graves' disea
se patients at first, second, and third trimesters and 4 months postpartum.
To measure and epitope-map thyroid-stimulating antibody and thyroid stimul
ating-blocking antibody activities, we used CHO cells transfected with wild
-type human TSH receptor or with several TSH receptor-LH/hCG receptor chime
ras: Mc1+2, Mc2, and Mc4. These chimeric cells have their respective TSH re
ceptor residues 9-165, 90-165, and 261-370 substituted with equivalent resi
dues of the LH/hCG receptor. Overall thyroid-stimulating antibody decreased
, whereas thyroid stimulating-blocking antibody increased progressively dur
ing pregnancy. TSH binding inhibitory Ig fluctuated in individual patients,
but overall the activities remained statistically un-changed. Thyroid stim
ulating-blocking antibody appeared in subjects who were either negative for
thyroid-stimulating antibody or whose thyroid-stimulating antibody activit
y increased or decreased during pregnancy. Epitope mapping showed that the
thyroid-stimulating antibodies were mainly directed against residues 9-165
of the N-terminus of the TSH receptor extracellular domain. All thyroid sti
mulating-blocking antibodies had blocking activities against residues 261-3
70 of the C-terminus of the ectodomain. However, the majority of the thyroi
d stimulating-blocking antibodies had a hybrid conformational epitope direc
ted against N-terminal residues 9-89 or 90-165 as well. Despite a change in
the activity level, we did not observe any change in the epitope of either
the stimulatory or blocking Abs as pregnancy advanced. In conclusion, a ch
ange in the specificity of TSH receptor antibody from stimulatory to blocki
ng activity was observed during pregnancy, and the appearance of thyroid st
imulating-blocking antibody may contribute to the remission of Graves' dise
ase during pregnancy.